0000000000285233

AUTHOR

Ratislav Bahleda

showing 2 related works from this author

LBA-5 Phase Ib study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic esophageal cancer

2021

OncologyTIGITbiologyAtezolizumabbusiness.industryCancer researchbiology.proteinMedicineIn patientHematologyAntibodybusinessMetastatic esophageal cancerAnnals of Oncology
researchProduct

51P Pooled analysis safety profile of futibatinib in patients with advanced solid tumors, including intrahepatic cholangiocarcinoma (iCCA)

2021

Oncologymedicine.medical_specialtySafety profilePooled analysisOncologybusiness.industryInternal medicinemedicineIn patientHematologybusinessIntrahepatic CholangiocarcinomaAnnals of Oncology
researchProduct